C. Low Et Al. , "Modulation of Interleukins in Sepsis-Associated Clotting Disorders: Interplay With Hemostatic Derangement," CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , vol.23, no.1, pp.34-39, 2017
Low, C. Et Al. 2017. Modulation of Interleukins in Sepsis-Associated Clotting Disorders: Interplay With Hemostatic Derangement. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , vol.23, no.1 , 34-39.
Low, C., Syed, D., Khan, D., TETİK, Ş., Walborn, A., Hoppensteadt, D., ... Mosier, M.(2017). Modulation of Interleukins in Sepsis-Associated Clotting Disorders: Interplay With Hemostatic Derangement. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , vol.23, no.1, 34-39.
Low, Christopher Et Al. "Modulation of Interleukins in Sepsis-Associated Clotting Disorders: Interplay With Hemostatic Derangement," CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , vol.23, no.1, 34-39, 2017
Low, Christopher Et Al. "Modulation of Interleukins in Sepsis-Associated Clotting Disorders: Interplay With Hemostatic Derangement." CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , vol.23, no.1, pp.34-39, 2017
Low, C. Et Al. (2017) . "Modulation of Interleukins in Sepsis-Associated Clotting Disorders: Interplay With Hemostatic Derangement." CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , vol.23, no.1, pp.34-39.
@article{article, author={Christopher Low Et Al. }, title={Modulation of Interleukins in Sepsis-Associated Clotting Disorders: Interplay With Hemostatic Derangement}, journal={CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS}, year=2017, pages={34-39} }